Skip to content
Tenfell
Awarded contract
Published 22 Apr 2024

Provision of Sequencing Equipment and Consumables

Guy's and St Thomas' NHS Foundation Trust · London

Key facts

Contract value
£376,110
Awarded
27 Mar 2024
Contract starts
31 Mar 2024
Contract ends
31 Mar 2026
Procedure
Negotiated procedure without prior publication (above threshold)
Buyer type
Health

Awarded to

SupplierValue
OXFORD NANOPORE TECHNOLOGIES PLC£376,110

Description

Guys and St Thomas's NHS Foundation Trust (GSTT) has been awarded Funding from NHS England (NHSE) and the Department of Science, Innovation and Technology (the "Funders") for the financial years 2023/24 and 2024/25 as the lead provider for the delivery of the Respiratory Metagenomic Clinical Service Development Programme (the 'Project'), from Oxford Nanopore Technologies PLC.

The Project is a pilot based on patented nanopore based sequencing technology and therefore this contract notice is issued under Regulation 32 (a) of the PCR 2015.

The Project aims to deliver a national respiratory metagenomics (RMg) pilot clinical service with an integrated biosecurity surveillance purpose, as a world-first programme to combine effective infectious disease management with rapid emerging pathogen detection and notification.

Categories (CPV)

Similar open tenders

About Guy's and St Thomas' NHS Foundation Trust

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.